Most cited article - PubMed ID 8180149
Anterior pituitary weight, cAMP, cGMP and prolactin levels after combined treatment with estradiol and methylene blue
Nitric oxide is a highly reactive gas that is produced by many tissues and exerts a series of physiological and pathophysiological effects. We studied the changes of the serum testosterone, thyroxine and thyrotropin levels, thyroid and anterior pituitary weights and thyroid cGMP concentrations in male Wistar strain rats treated with estradiol benzoate (EB) (1 mg/kg, im twice a week) and nonselective NO-synthase inhibitor L-NAME (N-omega-nitro-L-arginine methyl ester) alone and with combination of these substances. We have found that L-NAME in a dose 100 mg/kg/day but not in a dose 50 mg/kg/day increased the serum thyroxine and testosterone levels and in the case of testosterone in a higher dose partially blocked its drop when administered simultaneously with EB. The serum thyrotropin levels significantly fell after L-NAME and EB treatment. The cGMP thyroid levels changed only slightly in groups treated EB and L-NAME alone and were significantly decreased in group treated with combination of these substances. The nitric oxide thus seems to be an important modulator of thyroid and testicular function. The cGMP activation cascade is not probably involved in the nitric oxide induced changes of thyroid function.
- MeSH
- Pituitary Gland, Anterior drug effects metabolism MeSH
- Estradiol pharmacology MeSH
- Cyclic GMP metabolism MeSH
- Enzyme Inhibitors pharmacology MeSH
- Rats MeSH
- NG-Nitroarginine Methyl Ester administration & dosage pharmacology MeSH
- Rats, Wistar MeSH
- Thyroid Gland drug effects physiology MeSH
- Nitric Oxide Synthase antagonists & inhibitors MeSH
- Testosterone blood MeSH
- Thyrotropin blood MeSH
- Thyroxine blood MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Estradiol MeSH
- Cyclic GMP MeSH
- Enzyme Inhibitors MeSH
- NG-Nitroarginine Methyl Ester MeSH
- Nitric Oxide Synthase MeSH
- Testosterone MeSH
- Thyrotropin MeSH
- Thyroxine MeSH
The aim of this study was to find out whether mifepristone, known mainly as a substance with an antiprogesterone and antiglucocorticoid effect, also has an in vivo antiestrogenic activity on the adenohypophysis of the rat. Male Wistar rats were given chronically either estradiol-benzoate (EB, 1 mg s.c. twice a week) for a period of 12 days, or the non steroidal antiestrogen tamoxifen (1 mg/day/rat), or mifepristone (1 mg/day/rat), or EB together with mifepristone or tamoxifen. The hypertrophic effect of the EB on the weight of the adenohypophysis (AP) was significantly suppressed both by tamoxifen and by mifepristone. Mifepristone and tamoxifen reduced the increased content of PRL in the estrogenized adenohypophysis. Mifepristone but not tamoxifen significantly increased the content of the LH in the adenohypophysis of estrogen treated rats. Mifepristone and tamoxifen suppressed the increased concentration of cyclic nucleotides cAMP and cGMP in the estrogenized adenohypophysis. Mifepristone given alone increased serum levels of corticosterone, but when given together with EB deepened inhibiting effect EB on them. The results of our preliminary study show that mifepristone exerts a weak antiestrogenic activity on the level of hypophysis, however the pharmacology is not identical to tamoxifen.
- MeSH
- Pituitary Gland, Anterior drug effects MeSH
- Estrogen Antagonists administration & dosage pharmacology MeSH
- Estradiol administration & dosage analogs & derivatives pharmacology MeSH
- Drug Combinations MeSH
- Injections, Subcutaneous MeSH
- Corticosterone blood MeSH
- Rats MeSH
- Mifepristone administration & dosage pharmacology MeSH
- Rats, Wistar MeSH
- Tamoxifen administration & dosage pharmacology MeSH
- Body Weight drug effects MeSH
- Organ Size drug effects MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Estrogen Antagonists MeSH
- estradiol 3-benzoate MeSH Browser
- Estradiol MeSH
- Drug Combinations MeSH
- Corticosterone MeSH
- Mifepristone MeSH
- Tamoxifen MeSH